Detects a 12 kDa band corresponding to histone H4 in human cell lines (HeLa, A549, K562, HepG2) treated with 30 mM sodium butyrate .
Demonstrated efficacy in ChIP assays using HeLa cells, with enrichment observed at the β-globin promoter .
| Cell Line | Treatment | Band Intensity (WB) | Localization (ICC/IF) |
|---|---|---|---|
| HeLa | 30 mM sodium butyrate | Strong | Nuclear |
| A549 | 30 mM sodium butyrate | Moderate | Nuclear |
| K562 | 30 mM sodium butyrate | Weak | Nuclear |
| Untreated controls | None | Undetectable | N/A |
Data derived from multiple validation studies .
| Supplier | Catalog Number | Size | Price (USD) |
|---|---|---|---|
| Bio-Connect | CSB-PA010429PA12HIBHU | 100 µl | $319 |
| AFG Scientific | A25222 | 50 µl | $225 |
| Labprice | CAC15715 | N/A | $350 |
Pricing and availability may vary .
Specificity: Validated against the 2-hydroxyisobutyryl-K12 epitope via peptide competition assays . No cross-reactivity reported with other histone H4 modifications (e.g., acetylation, methylation) .
Limitations: Restricted to research use; not validated for diagnostic applications .
Histone H4’s 2-hydroxyisobutyrylation is implicated in transcriptional regulation and chromatin remodeling. Sodium butyrate, a histone deacetylase inhibitor, enhances this modification, suggesting a role in epigenetic stress responses .